267 related articles for article (PubMed ID: 20093809)
1. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors.
Brines M
Blood Purif; 2010; 29(2):86-92. PubMed ID: 20093809
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.
Brines M; Cerami A
J Intern Med; 2008 Nov; 264(5):405-32. PubMed ID: 19017170
[TBL] [Abstract][Full Text] [Related]
3. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
4. Does erythropoietin have a dark side? Epo signaling and cancer cells.
Sytkowski AJ
Sci STKE; 2007 Jul; 2007(395):pe38. PubMed ID: 17636183
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin is a multifunctional tissue-protective cytokine.
Erbayraktar S; Yilmaz O; Gökmen N; Brines M
Curr Hematol Rep; 2003 Nov; 2(6):465-70. PubMed ID: 14561390
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.
Fliser D; Haller H
Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185
[TBL] [Abstract][Full Text] [Related]
8. [Pleiotropic effects of erythropoietin].
Kes P; Basić-Jukić N; Furić-Cunko V
Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
[TBL] [Abstract][Full Text] [Related]
9. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.
Brines M; Cerami A
Kidney Int; 2006 Jul; 70(2):246-50. PubMed ID: 16738535
[TBL] [Abstract][Full Text] [Related]
10. The erythropoietin receptor in normal and cancer tissues.
Jelkmann W; Bohlius J; Hallek M; Sytkowski AJ
Crit Rev Oncol Hematol; 2008 Jul; 67(1):39-61. PubMed ID: 18434185
[TBL] [Abstract][Full Text] [Related]
11. The erythropoietin receptor and its expression in tumor cells and other tissues.
Farrell F; Lee A
Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
[TBL] [Abstract][Full Text] [Related]
12. Cellular protection by erythropoietin: new therapeutic implications?
Joyeux-Faure M
J Pharmacol Exp Ther; 2007 Dec; 323(3):759-62. PubMed ID: 17717190
[TBL] [Abstract][Full Text] [Related]
13. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
Rainville N; Jachimowicz E; Wojchowski DM
Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
[TBL] [Abstract][Full Text] [Related]
14. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and the nervous system.
Genc S; Koroglu TF; Genc K
Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
[TBL] [Abstract][Full Text] [Related]
16. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
Tao W; Wen F; Zhang H; Liu G
Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events.
van Rijt WG; van Goor H; Ploeg RJ; Leuvenink HG
Transpl Int; 2014 Mar; 27(3):241-8. PubMed ID: 23964738
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
King VR; Averill SA; Hewazy D; Priestley JV; Torup L; Michael-Titus AT
Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
[TBL] [Abstract][Full Text] [Related]
19. [Research advances in expression and functions of erythropoietin and erythropoietin receptor in cancers].
Li M; Lu Y; Chen XQ
Ai Zheng; 2008 Jun; 27(6):667-72. PubMed ID: 18570746
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
Liu R; Suzuki A; Guo Z; Mizuno Y; Urabe T
J Neurochem; 2006 Feb; 96(4):1101-10. PubMed ID: 16417583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
